Secure & Private Payments Encrypted checkout with crypto payment options
12 Underutilization of AUD medications is attributed to multiple factors, including few Food and Drug Administration (FDA)approved therapies, limited awareness of these medications, and barriers related to stigma
Patients who have had mixed or unclear GLP-1 responses in the past, or who want biomarker context before starting treatment, may benefit from PlexusDx's genetic-pathway option
You may always request to speak with one of our providers if you have questions regarding this
The problem starts when you reach for the bigger can or stack your sources without counting
A Phase 2 trial published in the New England Journal of Medicine (2023) reported significant weight reduction with retatrutide over 48 weeks, and further trials are registered on ClinicalTrials